Bivariate linkage between acylation-stimulating protein and BMI and high-density lipoproteins

Obesity Research

Volumn 12, Issue 4, 2004, Pages 669-678

  Martin, Lisa J ^a,b   Cianflone, Katherine ^c   Zakarian, Robert ^c   Nagrani, Gauri ^c   Almasy, Laura ^a   Rainwater, David L ^a   Cole, Shelley ^a   Hixson, James E ^d   MacCluer, Jean W ^a   Blangero, John ^a   Comuzzie, Anthony G ^a  

^a SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c MCGILL UNIVERSITY   (Canada)

^d UNIVERSITY OF TEXAS   (United States)

Author keywords

Acylation stimulating protein; Adipokines; Bivariate linkage analysis; C3adesArg; Mexican Americans

Indexed keywords

COMPLEMENT C3A, DES ARG (77); COMPLEMENT C3A, DES-ARG-(77); COMPLEMENT COMPONENT C3A; DRUG DERIVATIVE; HIGH DENSITY LIPOPROTEIN; PLASMA PROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BODY MASS; CHROMOSOME 15; CHROMOSOME 17; ETHNOLOGY; FEMALE; GENETIC LINKAGE; GENETICS; HISPANIC; HUMAN; MALE; METABOLIC SYNDROME X; MEXICO; MIDDLE AGED; OBESITY; QUANTITATIVE TRAIT LOCUS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD PROTEINS; BODY MASS INDEX; CHROMOSOMES, HUMAN, PAIR 15; CHROMOSOMES, HUMAN, PAIR 17; COMPLEMENT C3A; FEMALE; HISPANIC AMERICANS; HUMANS; LINKAGE (GENETICS); LIPOPROTEINS, HDL; LOD SCORE; MALE; METABOLIC SYNDROME X; MEXICO; MIDDLE AGED; OBESITY; QUANTITATIVE TRAIT LOCI;

EID: 3042767929     PISSN: 10717323     EISSN: None     Source Type: Journal    
DOI: 10.1038/oby.2004.77     Document Type: Article

References (54)

1. Ferrannini E, Haffner SM, Mitchell BD, Stern MP. Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia. 1991;34:416-22.
2. Despres JP, Lamarche B, Mauriege P, et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med. 1996;334:952-7.
3. Mitchell BD, Kammerer CM, Mahaney MC, et al. Genetic analysis of the IRS. Pleiotropic effects of genes influencing insulin levels on lipoprotein and obesity measures. Arterioscler Thromb Vasc Biol. 1996;16:281-8.
4. Despres JP, Prud'homme D, Pouliot MC, Tremblay A, Bouchard C. Estimation of deep abdominal adipose-tissue accumulation from simple anthropometric measurements in men. Am J Clin Nutr. 1991;54:471-7.
5. Pouliot MC, Despres JP, Lemieux S, et al. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol. 1994;73:460-8.
6. Haffner SM. Obesity and the metabolic syndrome: the San Antonio Heart Study. Br J Nutr. 2000;83(Suppl 1):S67-70.
7. Saleh J, Summers LK, Cianflone K, Fielding BA, Sniderman AD, Frayn KN. Coordinated release of acylation stimulating protein (ASP) and triacylglycerol clearance by human adipose tissue in vivo in the postprandial period. J Lipid Res. 1998;39:884-91.
8. Kalant D, Phelis S, Fielding BA, Frayn KN, Cianflone K, Sniderman AD. Increased postprandial fatty acid trapping in subcutaneous adipose tissue in obese women. J Lipid Res. 2000;41:1963-8.
9. Yasruel Z, Ciandone K, Sniderman AD, Rosenbloom M, Walsh M, Rodriguez MA. Effect of acylation stimulating protein on the triacylglycerol synthetic pathway of human adipose tissue. Lipids. 1991;26:495-9.
10. Xia Z, Sniderman AD, Cianflone K. ASP deficiency induces obesity resistance and increased energy expenditure in ob/ob mice. J Biol Chem 2002;277:45874-9.
11. Germinario R, Sniderman AD, Manuel S, Lefebvre SP, Baldo A, Cianflone K. Coordinate regulation of triacylglycerol synthesis and glucose transport by acylation-stimulating protein. Metabolism. 1993;42:574-80.
12. Van Harmelen V, Reynisdottir S, Cianflone K, et al. Mechanisms involved in the regulation of free fatty acid release from isolated human fat cells by acylation-stimulating protein and insulin. J Biol Chem. 1999;274:18243-51.
13. Maslowska M, Vu H, Phelis S, et al. Plasma acylation stimulating protein, adipsin and lipids in non-obese and obese populations. Eur J Clin Invest. 1999;29:679-86.
14. Comuzzie AG, Hixson JE, Almasy L, et al. A major quantitative trait locus determining serum leptin levels and fat mass is located on human chromosome 2. Nat Genet. 1997;15: 273-6.
15. Almasy L, Hixson JE, Rainwater DL, et al. Human pedigree-based quantitative-trait-locus mapping: localization of two genes influencing HDL-cholesterol metabolism. Am J Hum Genet. 1999;64:1686-93.
16. Rainwater DL, Almasy L, Blangero J, et al. A genome search identifies major quantitative trait loci on human chromosomes 3 and 4 that influence cholesterol concentrations in small LDL particles. Arterioscler Thromb Vasc Biol. 1999;19:777-83.
17. Green P, Falls K, Crooks S. Documentation for CRI-MAP, 2.4 ed. St. Louis, MO: Department of Genetics, School of Medicine; 1990.
18. Amos CI. Robust variance-components approach for assessing genetic linkage in pedigrees. Am J Hum Genet. 1994;54:535-43.
19. Blangero J, Almasy L. Multipoint oligogenic linkage analysis of quantitative traits. Genet Epidemiol. 1997;14:959-64.
20. Self S, Liang K. Asymptotic properties of maximum likelihood ratio tests under nonstandard conditions. J Am Stat Assoc. 1987;82:605-10.
21. Allison DB, Neale MC, Zannolli R, Schork NJ, Amos CI, Blangero J. Testing the robustness of the likelihood-ratio test in a variance-component quantitative-trait loci-mapping procedure. Am J Hum Genet. 1999;65:531-44.
22. Almasy L, Blangero J. Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet. 1998;62: 1198-211.
23. Goldgar DE. Multipoint analysis of human quantitative genetic variation. Am J Hum Genet. 1990;47:957-67.
24. Fulker DW, Cherny SS, Cardon LR. Multipoint interval mapping of quantitative trait loci, using sib pairs. Am J Hum Genet. 1995;56:1224-33.
25. Almasy L, Dyer TD, Blangero J. Bivariate quantitative trait linkage analysis: pleiotropy versus co-incident linkages. Genet Epidemiol. 1997;14:953-8.
26. Mitchell BD, Cole SA, Comuzzie AG, et al. A quantitative trait locus influencing BMI maps to the region of the beta-3 adrenergic receptor. Diabetes. 1999;48:1863-7.
27. Cianflone K, Maslowska M, Sniderman AD. Acylation stimulating protein (ASP), an adipocyte autocrine: new directions. Semin Cell Dev Biol. 1999;10:31-41.
28. Kalant D, Cain SA, Maslowska M, Sniderman AD, Cianflone K, Monk PN. The chemoattractant receptor-like protein C5L2 binds the C3a des-Arg77/acylation- stimulating protein. J Biol Chem. 2003;278:11123-9.
29. Cianflone K, Xia Z, Chen LY. Critical review of acylation-stimulating protein physiology in humans and rodents. Biochim Biophys Acta. 2003;1609:127-43.
30. Comuzzie AG, Blangero J, Mahaney MC, et al. Genetic and environmental correlations among hormone levels and measures of body fat accumulation and topography. J Clin Endocrinol Metab. 1996;81:597-600.
31. Comuzzie AG, Blangero J, Mahaney MC, Mitchell BD, Stern MP, MacCluer JW. Genetic and environmental correlations among skinfold measures. Int J Obes Relat Metab Disord. 1994;18:413-8.
32. Williams JT, Van Eerdewegh P, Almasy L, Blangero J. Joint multipoint linkage analysis of multivariate qualitative and quantitative traits. I. Likelihood formulation and simulation results. Am J Hum Genet. 1999;65:1134-47.
33. Murray I, Havel PJ, Sniderman AD, Cianflone K. Reduced body weight, adipose tissue, and leptin levels despite increased energy intake in female mice lacking acylation-stimulating protein. Endocrinology. 2000;141:1041-9.
34. Murray I, Sniderman AD, Cianflone K. Mice lacking acylation stimulating protein (ASP) have delayed postprandial triglyceride clearance. J Lipid Res. 1999;40:1671-6.
35. Kissebah AH, Sonnenberg GE, Myklebust J, et al. Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome. Proc Natl Acad Sci U S A. 2000;97:14478-83.
36. Guo N, Weremowicz S, Lynch N, et al. Assignment of C1QBP encoding the C1q globular domain binding protein (gC1q-R) to human chromosome 17 band p13.3 by in situ hybridization. Cytogenet Cell Genet. 1997;77:283-4.
37. Ghebrehiwet B, Jesty J, Peerschke EI. gC1q-R/p33: structure-function predictions from the crystal structure. Immunobiology. 2002;205:421-32.
38. Ghebrehiwet B, Lim BL, Kumar R, Feng X, Peerschke EI. gC1q-R/p33, a member of a new class of multifunctional and multicompartmental cellular proteins, is involved in inflammation and infection. Immunol Rev. 2001;180:65-77.
39. Braun L, Ghebrehiwet B, Cossart P. gC1q-R/p32, a C1q-binding protein, is a receptor for the InlB invasion protein of Listeria monocytogenes. Embo J. 2000;19:1458-66.
40. Majumdar M, Meenakshi J, Goswami SK, Datta K. Hyaluronan binding protein 1 (HABP1)/C1QBP/p32 is an endogenous substrate for MAP kinase and is translocated to the nucleus upon mitogenic stimulation. Biocliem Biophys Res Commun. 2002;291:829-37.
41. Fan Y-S, Eddy RL, Byers MG, et al. Assignment of genes encoding three human glucose transporter/transporter-like proteins (GLUT4, GLUT5 and GLUT6) to chromosomes 17, 1 and 5, respectively. Cytogenet Cell Genet. 1989;51:997.
42. Maslowska M, Sniderman AD, Germinario R, Cianflone K. ASP stimulates glucose transport in cultured human adipocytes. Int J Obes Relat Metab Disord. 1997;21:261-6.
43. Katz EB, Stenbit AE, Hatton K, DePinho R, Charron MJ. Cardiac and adipose tissue abnormalities but not diabetes in mice deficient in GLUT4. Nature. 1995;377:151-5.
44. Wallberg-Henriksson H, Zierath JR. GLUT4: a key player regulating glucose homeostasis? Insights from transgenic and knockout mice. Mol Membr Biol. 2001;18:205-11.
45. Gnudi L, Shepherd PR, Kahn BB. Over-expression of GLUT4 selectively in adipose tissue in transgenic mice: implications for nutrient partitioning. Proc Nutr Soc. 1996;55:191-9.
46. Lander E, Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet. 1995;11:241-7.
47. Sparkes RS, Zollman S, Klisak I, et al. Human genes involved in lipolysis of plasma lipoproteins: mapping of loci for lipoprotein lipase to 8p22 and hepatic lipase to 15q21. Genomics. 1987;1:138-44.
48. Datta S, Luo CC, Li WH, et al. Human hepatic lipase. Cloned cDNA sequence, restriction fragment length polymorphisms, chromosomal localization, and evolutionary relationships with lipoprotein lipase and pancreatic lipase. J Biol Chem. 1988;263:1107-10.
49. Silverman DI, Ginsburg GS, Pasternak RC. High-density lipoprotein subfractions. Am J Med. 1993;94:636-45.
50. Juo SH, Han Z, Smith JD, Colangelo L, Liu K. Promoter polymorphisms of hepatic lipase gene influence HDL(2) but not HDL(3) in African American men: CARDIA study. J Lipid Res. 2001;42:258-64.
51. Guerra R, Wang J, Grundy SM, Cohen JC. A hepatic lipase (LIPC) allele associated with high plasma concentrations of high density lipoprotein cholesterol. Proc Natl Acad Sci U S A. 1997;94:4532-7.
52. Su Z, Zhang S, Nebert DW, et al. A novel allele in the promoter of the hepatic lipase is associated with increased concentration of HDL-C and decreased promoter activity. J Lipid Res. 2002;43:1595-601.
53. Grundy SM, Vega GL, Otvos JD, Rainwater DL, Cohen JC. Hepatic lipase activity influences high density lipoprotein subclass distribution in normotriglyceridemic men. Genetic and pharmacological evidence. J Lipid Res. 1999;40:229-34.
54. Deeb SS, Peng R. The C-514T polymorphism in the human hepatic lipase gene promoter diminishes its activity. J Lipid Res. 2000;41:155-8.